Please Wait
Applying Filters...
menu
    • menu
    FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector 2025 highlights: FDA approves pill version of Novo’s Wegovy; BioMarin acquires Amicus for US$ 4.8 bn

    Stock Recap
    #PipelineProspector

    Menu

    Moroctocog Alfa

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Labeler NDC Package Code Non Proprietary Name Start Marketing Date End Marketing Date Category Code Dosage Form (Strength)
    30/12/2025 Patheon
    U.S.A
    		 Patheon Italia S.p.A. 68225-098 EFMOROCTOCOG ALFA 2014-07-14 2026-12-31 DRUG FOR FURTHER PROCESSING POWDER, FOR SOLUTION (6000[iU]/3mL)
    30/12/2025 Patheon
    U.S.A
    		 Patheon Italia S.p.A. 68225-097 EFMOROCTOCOG ALFA 2014-07-14 2026-12-31 DRUG FOR FURTHER PROCESSING POWDER, FOR SOLUTION (5000[iU]/3mL)
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.